We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 2 februari 2017

Oncogene - Table of Contents alert Volume 36 Issue 5

If you are unable to see the message below, click here to view.
Oncogene

TABLE OF CONTENTS

Volume 36, Issue 5 (February 2017)

In this issue
Review
Original Articles
Short Communications

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Review

Top

Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy

M Michelle Xu, Y Pu, R R Weichselbaum and Y-X Fu

Oncogene 2017 36: 585-592; advance online publication, July 18, 2016; 10.1038/onc.2016.231

Abstract | Full Text

Original Articles

Top

Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion

E B Berens, G M Sharif, M O Schmidt, G Yan, C W Shuptrine, L M Weiner, E Glasgow, A T Riegel and A Wellstein

Oncogene 2017 36: 593-605; advance online publication, July 4, 2016; 10.1038/onc.2016.234

Abstract | Full Text

CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence OPEN

N Garg, D Bakhshinyan, C Venugopal, S Mahendram, D A Rosa, T Vijayakumar, B Manoranjan, R Hallett, N McFarlane, K H Delaney, J M Kwiecien, C C Arpin, P-S Lai, R F Gómez-Biagi, A M Ali, E D de Araujo, O A Ajani, J A Hassell, P T Gunning and S K Singh

Oncogene 2017 36: 606-617; advance online publication, October 24, 2016; 10.1038/onc.2016.235

Abstract | Full Text

Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer

Q Su, B Zhang, L Zhang, T Dang, D Rowley, M Ittmann and L Xin

Oncogene 2017 36: 618-627; advance online publication, June 27, 2016; 10.1038/onc.2016.232

Abstract | Full Text

CD84 mediates CLL-microenvironment interactions

A Marom, A F Barak, M P Kramer, H Lewinsky, I Binsky-Ehrenreich, S Cohen, A Tsitsou-Kampeli, V Kalchenko, Y Kuznetsov, V Mirkin, N Dezorella, M Shapiro, P L Schwartzberg, Y Cohen, L Shvidel, M Haran, S Becker-Herman, Y Herishanu and I Shachar

Oncogene 2017 36: 628-638; advance online publication, July 25, 2016; 10.1038/onc.2016.238

Abstract | Full Text

Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis

Z Deng, Y Rong, Y Teng, X Zhuang, A Samykutty, J Mu, L Zhang, P Cao, J Yan, D Miller and H-G Zhang

Oncogene 2017 36: 639-651; advance online publication, June 27, 2016; 10.1038/onc.2016.229

Abstract | Full Text

Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer

A R Garcia-Rendueles, J S Rodrigues, M E R Garcia-Rendueles, M Suarez-Fariña, S Perez-Romero, F Barreiro, I Bernabeu, J Rodriguez-Garcia, L Fugazzola, T Sakai, F Liu, J Cameselle-Teijeiro, S B Bravo and C V Alvarez

Oncogene 2017 36: 652-666; advance online publication, July 25, 2016; 10.1038/onc.2016.233

Abstract | Full Text

Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy

M Gugnoni, V Sancisi, G Gandolfi, G Manzotti, M Ragazzi, D Giordano, I Tamagnini, M Tigano, A Frasoldati, S Piana and A Ciarrocchi

Oncogene 2017 36: 667-677; advance online publication, July 4, 2016; 10.1038/onc.2016.237

Abstract | Full Text

PERK inhibits DNA replication during the Unfolded Protein Response via Claspin and Chk1

E Cabrera, S Hernández-Pérez, S Koundrioukoff, M Debatisse, D Kim, M B Smolka, R Freire and D A Gillespie

Oncogene 2017 36: 678-686; advance online publication, July 4, 2016; 10.1038/onc.2016.239

Abstract | Full Text

Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition

Q Zhang, S Liu, K R Parajuli, W Zhang, K Zhang, Z Mo, J Liu, Z Chen, S Yang, A R Wang, L Myers and Z You

Oncogene 2017 36: 687-699; advance online publication, July 4, 2016; 10.1038/onc.2016.240

Abstract | Full Text

MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic target OPEN

Y H Sheng, Y He, S Z Hasnain, R Wang, H Tong, D T Clarke, R Lourie, I Oancea, K Y Wong, J W Lumley, T H Florin, P Sutton, J D Hooper, N A McMillan and M A McGuckin

Oncogene 2017 36: 700-713; advance online publication, July 11, 2016; 10.1038/onc.2016.241

Abstract | Full Text

Short Communications

Top

Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells

R Eguchi, T Nakano and I Wakabayashi

Oncogene 2017 36: 714-722; advance online publication, June 27, 2016; 10.1038/onc.2016.226

Abstract | Full Text

p53 binds the mdmx mRNA and controls its translation

A-S Tournillon, I López, L Malbert-Colas, S Findakly, N Naski, V Olivares-Illana, K Karakostis, B Vojtesek, K Nylander and R Fåhraeus

Oncogene 2017 36: 723-730; advance online publication, July 4, 2016; 10.1038/onc.2016.236

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group